|
Volumn 48, Issue 4, 1998, Pages 396-402
|
Apolipoprotein E*3-Leiden transgenic mice mode for hypolipidaemic drugs
a b c d b b b e,g a,f b
a
TNO
(Netherlands)
|
Author keywords
CAS 154566 12 8; Gemfibrozil; Hypolipidaemic drugs, testing in transgenic mice; Lovastatin; SB 204990, hypolipidaemic effect; (3R*,5S*)3 Carboxy 11 (2,4 dichlorophenyl) 3,5 dihydroxyundecanoic acid, 5 ring lactone
|
Indexed keywords
3 CARBOXY 11 (2,4 DICHLOROPHENYL) 3,5 DIHYDROXYUNDECANOIC ACID;
ANTILIPEMIC AGENT;
APOLIPOPROTEIN C3;
APOLIPOPROTEIN E3;
CHOLESTEROL;
GEMFIBROZIL;
HIGH DENSITY LIPOPROTEIN;
LIPOPROTEIN LIPASE;
LOW DENSITY LIPOPROTEIN;
MESSENGER RNA;
MEVINOLIN;
SB 204990;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
VERY LOW DENSITY LIPOPROTEIN;
ANTICOAGULANT AGENT;
APOLIPOPROTEIN E;
HEPARIN;
LACTONE;
LIPID;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
ATHEROSCLEROSIS;
CHOLESTEROL BLOOD LEVEL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFECT;
ENZYME ACTIVITY;
GENE EXPRESSION;
HYPERLIPIDEMIA;
LIPOPROTEIN BLOOD LEVEL;
MALE;
MOUSE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
TRANSGENIC MOUSE;
ANIMAL;
BIOSYNTHESIS;
BLOOD;
C57BL MOUSE;
DRUG SCREENING;
GENETICS;
LIVER;
METABOLISM;
PHYSIOLOGY;
ANIMALS;
ANTICOAGULANTS;
ANTILIPEMIC AGENTS;
APOLIPOPROTEIN E3;
APOLIPOPROTEINS E;
CHOLESTEROL;
DRUG EVALUATION, PRECLINICAL;
GEMFIBROZIL;
HEPARIN;
LACTONES;
LIPIDS;
LIPOPROTEIN LIPASE;
LIVER;
LOVASTATIN;
MALE;
MICE;
MICE, INBRED C57BL;
MICE, TRANSGENIC;
RNA, MESSENGER;
TRIGLYCERIDES;
|
EID: 15444342298
PISSN: 00044172
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (29)
|
References (25)
|